Method for increasing lincomycin yield by knocking out streptomyces lincomycin ectA gene

By knocking out Streptomyces ectA gene, blocking the tetrahydropyrimidine synthesis pathway, the problem of time-consuming, labor-intensive and randomness of traditional mutagenesis methods is solved, and the production of lincomycin is significantly improved, providing an efficient High yield method.

CN118910115APending Publication Date: 2024-11-08NINGXIA UNIVERSITY
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411122596.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Traditional physical or chemical mutagenesis methods are used to increase lincomycin production time-consuming and stochastic, which is difficult to meet the needs of industrial production.

Method used

By knocking out the ectA gene in Streptomyces lincosids, blocking the tetrahydropyrimidine synthesis pathway, reducing the biosynthesis of the competitive substrate tetrahydropyrimidine, increasing the allocation of nutrients and energy into the lincosids synthesis process, thereby improving the lincosids lincosids synthesis fermentation yield of vegetative.

Benefits of technology

The fermentation yield of lincomycin was significantly improved, and the lincomycin yield of the ectA gene deletion Streptomyces mutant strain of ectA gene increased by 107.5% compared with the wild type, achieving efficient and stable high-yield production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910115A_ABST
    Figure CN118910115A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of gene engineering, and particularly relates to a method for increasing the yield of lincomycin by knocking out a streptomyces lincomycin ectA gene. The method comprises the following steps: knocking out an ectA gene of streptomyces lincomycin, and fermenting the obtained mutant strain to produce lincomycin. Experimental results show that after the ectA gene of the streptomyces lincomycin is deleted, the yield of the lincomycin is remarkably increased. The invention also provides a construction method of the ectA gene deletion type streptomyces lincolensis mutant strain, according to the method, the coding gene of the streptomyces lincolensis is directionally modified through a gene engineering technology, the ectA gene is substituted by a gene irrelevant to tetrahydropyrimidine synthesis, and the obtained ectA gene deletion type streptomyces lincolensis mutant strain is a lincomycin high-yield engineering strain. The method can be used for efficiently producing lincomycin or a product in the synthesis process of lincomycin.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of gene engineering, and in particular relates to a method for improving the yield of lincomycin by knocking out the ectA gene of Streptomyces lincomycin. Background Art

[0002] Lincomycin is produced by Streptomyces lincolnensis and is a lincosamide antibiotic widely used to treat infectious diseases caused by Gram-positive bacteria. It can be used as a veterinary antibiotic to treat dysentery and necrotic enteritis in poultry and livestock. It can also be used as a clinical drug, especially in cases where mixed microbial communities of anaerobic and aerobic bacteria are expected to produce synergistic effects, such as bone and joint infections, prevention of postoperative intra-abdominal infections, oral infections, anaerobic sepsis, skin and mucosal infections, etc. It is also used to treat periodontitis. Lincomycin is also an effective alternative to penicillin and its derivatives in the treatment of upper respiratory tract infections in patients allergic to penicillin. my country is a major producer and exporter of lincomycin API. With the development of my country's breeding and animal husbandry, the demand for lincomycin antibiotics is increasing, and it is particularly important to increase the production of lincomycin.

[0003] At present, industrial production strains of lincomycin are mainly obtained through physical or chemical mutagenesis methods. However, traditional mutagenesis technology is not only time-consuming and labor-intensive, but also highly random and cannot meet the needs of increasing lincomycin production. Summary of the invention

[0004] In view of the above problems, the present invention provides a method for increasing the yield of lincomycin by knocking out the ectA gene of Streptomyces lincomycin. The present invention significantly increases the fermentation yield of lincomycin by knocking out the ectA gene encoding 2,4-diaminobutyric acid acetyltransferase in the ectoine synthesis pathway of Streptomyces lincomycin.

[0005] In order to achieve the above-mentioned object of the invention, the present invention adopts the following technical scheme:

[0006] The first aspect of the present invention provides a method for increasing lincomycin production by knocking out the ectA gene of Streptomyces lincomycin: the ectA gene of Streptomyces lincomycin is knocked out, and the obtained mutant is used to ferment and produce lincomycin, wherein the nucleotide sequence of the ectA gene is shown in SEQ ID NO.1.

[0007] Nucleotide sequence of ectA gene (SEQ ID NO.1):

[0008] ATGACTGCCGCACAAGCAGACCTGCACATCGACCGCCCGACGGTGGCCGACGGCGCCGCACTGTGGCGGATGGCAAAGGACTCGAAGGTCCTGGACCTGAACTCGTCCTACAGCTATCTGCTGTGGTGCC GCGACTTCGCCGCCACGTCCGCCGTGGCGCGCGACGAGCACGGCGAGCCGGTCGGCTTCGTCACCGGATACCTCCGGCCGGACCACCCGGCCACCCTGCTCGTCTGGCAGGTCGCGGTGGACGAGGCACA CCGCGGCCGCGGACTCGCCGCCGCCCTGCTGGACGGGCTGGTCGCACGGACCGCCCTGGAGCACGGAACCAGCACCGTCGAGACCACGATCACGCCGGGCAACATCGCCTCCGAACGCCTGTTCACGTCG TTCGCCGAGCGTCACGGCGCCCGGCTGGAGCGCGAGGTGCTGTTCGACACGGCCCTGTTCCCCGACGGGCCGCACGACCCCGAGGTCCTGTACCGCATCGGCCCCCTGTCCCTGACTCCCTCTGCCTGA.

[0009] The biosynthesis of lincomycin and ectoine both use L-aspartic acid (L-Asp) as a precursor, and the two are in a competitive substrate relationship. EctA is the coding gene of 2,4-diaminobutyric acid acetyltransferase in the ectoine synthesis pathway of Streptomyces lincomycin. The present invention blocks the ectoine pathway by knocking out the ectA gene, so that more nutrients and energy are enriched in the synthesis process of lincomycin, thereby significantly improving the fermentation yield of lincomycin.

[0010] The second aspect of the present invention provides a method for constructing an ectA gene-deficient mutant of Streptomyces lincomyces: the ectA gene in Streptomyces lincomyces is replaced by a gene unrelated to ectoine synthesis through genetic engineering; wherein the nucleotide sequence of the ectA gene is shown in SEQ ID NO.1.

[0011] Preferably, the construction method uses Streptomyces lincomyces NBRC13054 as the starting strain.

[0012] Preferably, the gene unrelated to ectoine synthesis is an ampicillin resistance gene.

[0013] Further preferably, the construction method specifically comprises the following steps:

[0014] S1. Using the genomic DNA of Streptomyces lincomyces NBRC13054 as a template, and using ectA-UF and ectA-UR as well as ectA-DF and ectA-DR as primers, the upstream and downstream homologous arms of the ectA gene were amplified by PCR reaction, respectively. The nucleotide sequences of ectA-UF, ectA-UR, ectA-DF and ectA-DR are shown in SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4 and SEQ ID NO.5, respectively. Using the pUC57-AMP plasmid as a template, and using AMP-F and AMP-R as primers, the ampicillin resistance gene was amplified by PCR reaction. The nucleotide sequences of AMP-F and AMP-R are shown in SEQ ID NO.6 and SEQ ID NO.7, respectively.

[0015] S2, double-digest the PKC1139 plasmid, and connect the resulting digestion product with the upstream and downstream homology arms and the ampicillin resistance gene obtained in S1 to obtain the PKC1139-ΔectA knockout vector;

[0016] S3, transforming the PKC1139-ΔectA knockout vector into competent Escherichia coli cells, and culturing them as donor strains;

[0017] S4. The donor strain and mycelium of Streptomyces lincomyces are co-cultured in an antibiotic-free culture medium to form a mist of bacteria, which are then covered with antibiotics and cultured until conjugates grow. The mutant strain of Streptomyces lincomyces with ectA gene deletion is obtained through screening.

[0018] The above steps transform the coding gene of Streptomyces lincomycin by genetic engineering technology, so that the ectA gene is replaced by an ampicillin resistance gene that is not related to ectoine synthesis, thereby obtaining a high-yield engineered strain of lincomycin, that is, an ectA gene-deficient mutant of Streptomyces lincomycin. The mutant can be used to efficiently produce lincomycin or a product in its synthesis process.

[0019] In the construction method, the primers used to amplify the upstream and downstream homologous arms of the ectA gene are prone to non-specific bands during PCR amplification, and there are mixed bands around the target band. The above ectA-UF, ectA-UR, ectA-DF and ectA-DR are obtained after multiple designs and have good specificity.

[0020] Preferably, the reaction system of PCR in S1 is:

[0021]

[0022] The PCR reaction conditions were as follows: pre-denaturation at 95°C for 3 min; denaturation at 95°C for 30 s, annealing at 70°C for 30 s, extension at 72°C for 1 min, 35 cycles; and final extension at 72°C for 5 min.

[0023] Preferably, the endonucleases used for double digestion of the PKC1139 plasmid in S2 are XbaI and EcoRI.

[0024] Further preferably, the double enzyme digestion reaction system is:

[0025]

[0026] The reaction conditions of the double enzyme digestion are: digestion at 37°C for 3h and inactivation at 65°C.

[0027] Preferably, S2 uses Clon IIOne Step Cloning Kit C113 ligase connects the enzyme cleavage product to the upstream and downstream homology arms and the ampicillin resistance gene through enzyme ligation reaction.

[0028] Further preferably, the enzyme-linked reaction system is:

[0029]

[0030] The enzyme ligation reaction conditions were: ligation at 37°C for 30 min.

[0031] In the above enzyme ligation reaction system, the amount and ratio of each component are crucial to whether the ligation can be successful. Inappropriate addition ratio will cause ligation failure.

[0032] Preferably, the Escherichia coli competent cells in S3 are ET12567 Escherichia coli competent cells; and the Streptomyces lincomyces in S4 are Streptomyces lincomyces NBRC13054.

[0033] Preferably, the specific operation method of S4 is: mixing the bacterial suspension of the donor strain with the mycelial suspension of Streptomyces lincomyces, centrifuging, discarding the supernatant, culturing the bacterial liquid on an antibiotic-free WL-50 plate until a mist of bacteria is formed on the surface, covering it with apramycin and sodium nalidixic acid, and culturing until conjugates grow, and obtaining a mutant strain of Streptomyces lincomyces with a deleted ectA gene through screening.

[0034] Further preferably, the antibiotics are apramycin and sodium nalidixate, which are covered in the form of a solution, dried after covering, and then inverted for culture. Further preferably, the volume of the solution of apramycin and sodium nalidixate is 10 times the volume of the bacterial solution, the concentration of the apramycin solution is 1 mg / mL, and the concentration of the sodium nalidixate solution is 0.5 mg / mL. The dosage and concentration of the two can ensure that they have resistance and can be used for covering.

[0035] The third aspect of the present invention provides an ectA gene-deficient mutant strain of Streptomyces lincomyces constructed by the above construction method.

[0036] The fourth aspect of the present invention provides the use of the above-mentioned ectA gene-deficient mutant strain of Streptomyces lincomycin in the fermentation production of lincomycin.

[0037] Preferably, the ectA gene-deficient mutant of Streptomyces lincomyces is firstly freed from the PKC1139-ΔectA knockout vector, then cultured in a primary fermentation medium for 2 to 4 days at a fermentation temperature of 28°C, and then inoculated into a secondary fermentation medium for fermentation and culture for 6 to 8 days at a fermentation temperature of 28°C; the components of the primary fermentation medium are: 10 g / L glucose, 20 g / L soluble starch, 10 g / L soybean cake powder, 3 g corn steep liquor, 4 g / L CaCO3, 1.5 g / L (NH4)2SO4, and pH = 7.0-7.2; the components of the secondary fermentation medium are: 100 g / L glucose, 20 g / L soybean cake powder, 1.5 g / L (NH4)2SO4, 1.5 g / L corn steep liquor, 8 g / L NaNO3, 0.3 g / L K2HPO3, 8 g / L CaCO3, and pH = 7.0-7.2.

[0038] The beneficial effects of the present invention are as follows: from the perspective of the relationship between competitive substrates, the present invention knocks out the ectA gene in the lincomycin ectoine synthesis pathway, reduces the biosynthesis of ectoine, and enriches the precursor substance into the lincomycin synthesis pathway as much as possible, thereby significantly improving the yield of lincomycin produced by fermentation of Streptomyces lincomycin. The results show that after the ectA gene is deleted, the yield of lincomycin is extremely significantly increased. The construction method of the ectA gene-deficient lincomycin mutant strain provided by the present invention is to transform the coding gene of Streptomyces lincomycin by genetic engineering technology, thereby obtaining a lincomycin high-yield engineered strain, and the obtained engineered strain can be used for the efficient production of lincomycin or the product in its synthesis process. The experiment verified that the average yield of lincomycin in the fermentation broth of the ectA gene-deficient lincomycin mutant strain obtained by the construction method can reach 201.47 mg / L, and the maximum yield can reach 239.67 mg / L. Compared with the average yield of lincomycin of 115.50 mg / L in the fermentation broth of the wild-type NBRC13054 strain, the yield of lincomycin produced by fermentation of the ectA gene-deficient lincomycin mutant strain is 107.5% higher than that of the wild-type strain. The present invention provides a stable and feasible new method for increasing the yield of lincomycin, and can provide theoretical guidance for the precise and efficient production of high-yield lincomycin. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 This is the electrophoresis diagram of the amplified products of the upstream and downstream homology arms of ectA in Example 1;

[0040] Figure 2 This is the electrophoresis diagram of the AMP gene amplification product in Example 1;

[0041] Figure 3 The plasmid map of PKC1139 in Example 1;

[0042] Figure 4 The PKC1139 plasmid digestion product and the PKC1139 plasmid electrophoresis diagram in Example 1; M: Marker 1KbLadder; 1: PKC1139 plasmid double digestion product; 2: original PKC1139 plasmid;

[0043] Figure 5 Schematic diagram of the restriction sites of the double restriction enzyme digestion of PKC1139 plasmid in Example 1;

[0044] Figure 6 This is the PCR result of the positive clone of the ectA gene knockout vector in Example 1;

[0045] Figure 7 This is a schematic diagram of the construction process of the PKC1139-ΔectA knockout vector in Example 1;

[0046] Figure 8 This is the PCR verification result of the PKC-ΔectA plasmid clone in Example 2;

[0047] Fig. 9 This is a schematic diagram of the principle of homologous recombination in Example 2;

[0048] Fig.10 Schematic diagram of the design of detection primers in Example 2;

[0049] Fig.11 The PCR verification result of the ΔectA strain in Example 2;

[0050] Fig.12 The results of PKC1139-ΔectA plasmid elimination in Example 2; the left picture is an Apr-resistant WL-50 plate; the right picture is a non-resistant WL-50 plate;

[0051] Fig.13 The growth curves of the ΔectA mutant and the NBRC3054 strain in Example 2;

[0052] Fig.14 It is the lincomycin standard curve in Example 3;

[0053] Fig.15 The HPLC chromatogram of lincomycin standard in Example 3;

[0054] Fig.16The HPLC graphs of lincomycin after dilution of the fermentation broth of NBRC13054 strain and ΔectA strain in Example 4; A: HPLC chromatogram of lincomycin; B: bar graph of lincomycin yield. DETAILED DESCRIPTION

[0055] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work fall within the scope of protection of the present invention.

[0056] Lincomycin is a broad-spectrum antibiotic that can inhibit most Gram-positive bacteria. It has a wide range of applications and a large market demand, so increasing its production is particularly important. Currently, strains that biosynthesize lincomycin are mainly obtained through physical or chemical mutagenesis methods. However, traditional mutagenesis technology is not only time-consuming and labor-intensive, but also highly random and cannot fully meet the needs of efficient production of lincomycin.

[0057] To solve this problem, an embodiment of the present invention provides a method for increasing the yield of lincomycin by knocking out the ectA gene of Streptomyces lincomycin: the ectA gene of Streptomyces lincomycin is knocked out, and the resulting mutant is used to ferment and produce lincomycin. The ectA gene is a gene encoding 2,4-diaminobutyric acid acetyltransferase in the synthesis pathway of ectoine, which competes with lincomycin for substrates. By knocking out the gene, the method reduces the biosynthesis of ectoine, so that more nutrients and energy are enriched in the synthesis process of lincomycin, thereby significantly increasing the fermentation yield of lincomycin.

[0058] The embodiment of the present invention also provides a method for constructing a mutant strain of Streptomyces lincomyces with ectA gene deletion.

[0059] The embodiment of the present invention also provides an ectA gene-deficient mutant strain of Streptomyces lincomyces constructed by the above construction method.

[0060] The present invention also provides the use of the ectA gene-deficient lincomycin mutant strain in the fermentation production of lincomycin.

[0061] The scheme of the present invention is described below through specific embodiments.

[0062] The experimental strains and plasmids used in the following examples are shown in Table 1.

[0063] Table 1 Experimental strains and plasmids

[0064]

[0065]

[0066] Among them, the AMP gene sequence is as shown in SEQ ID NO.8:

[0067] Atgagtattcaacatttccgtgtcgcccttattcccttttttgcggcattttgccttcctgtttttgctcacccagaaacgctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggttacatcgaactggatctcaacagcggtaagatccttgagagttttcgccccgaagaacgttttccaatgatgagcacttttaaagttctgctatgtggcgcggtattatcccgtattgacgccgggcaagagcaactcggtcgccgcatacactattctcagaatgacttggttgagtactcaccagtcacagaaaagcatcttacggatggcatgacagtaagagaattatgcagtgctgccataaccatgagtgataacactgcggccaacttacttctgacaacgatcggaggaccgaaggagctaaccgcttttttgcacaacatgggggatcatgtaactcgccttgatcgttgggaaccggagctgaatgaagccataccaaacgacgagcgtgacaccacgatgcctgtagcaatggcaacaacgttgcgcaaactattaactggcgaactacttactctagcttcccggcaacaattaatagactggatggaggcggataaagttgcaggaccacttctgcgctcggcccttccggctggctggtttattgctgataaatctggagccggtgagcgtgggtctcgcggtatcattgcagcactggggccagatggtaagccctcccgtatcgtagttatctacacgacggggagtcaggcaactatggatgaacgaaatagacagatcgctgagataggtgcctcactgattaagcattggtaa。

[0068] The culture medium used in the following examples is as follows:

[0069] LB liquid medium: yeast extract 5g / L, tryptone 10g / L, sodium chloride 10g / L;

[0070] WL-50 medium: yeast extract 1g / L, soluble starch 5g / L, sodium chloride 2.5g / L, magnesium sulfate 3.6g / L, L-alanine 0.2g / L, L-arginine 0.2g / L, L-asparagine 0.5g / L, magnesium chloride 4.8g / L;

[0071] ISP-2 medium: malt extract 10 g / L, yeast extract 4 g / L, glucose 4 g / L, peptone 4 g / L, pH = 7.3;

[0072] 2×YT medium was purchased from Qingdao Hi-Tech Park Haibo Biotechnology Co., Ltd., product number HBDC003;

[0073] Primary fermentation medium: glucose 10g / L, soluble starch 20g / L, soybean cake powder 10g / L, corn steep liquor 3g, CaCO3 4g / L, (NH4)2SO4 1.5g / L, pH=7.0-7.2;

[0074] Secondary fermentation medium: glucose 100 g / L, soybean cake powder 20 g / L, (NH4)2SO4 1.5 g / L, corn steep liquor 1.5 g / L, NaNO3 8 g / L, K2HPO3 0.3 g / L, CaCO3 8 g / L, pH = 7.0-7.2.

[0075] The endonucleases used in the following examples were purchased from NEB.

[0076] Unless otherwise specified, the technical means used in the following examples are conventional means well known to those skilled in the art; the materials, reagents, etc. used in the following examples can be obtained from commercial channels.

[0077] Example 1

[0078] This example provides a process for constructing a knockout plasmid for the ectA gene.

[0079] 1. Obtaining homology arms

[0080] The genomic DNA of Streptomyces lincomyces NBRC13054 was used as a template, and the primer pairs ectA-UF / ectA-UR and ectA-DF / ectA-DR were used to amplify the upstream and downstream homologous arms of the ectA gene by polymerase chain reaction (PCR); the 5' end of the upstream primer was added with an XbaⅠ restriction site, and the 5' end of the downstream primer was added with an EcoRⅠ restriction site. Primers AMP-F and AMP-R were designed using the pUC57-AMP plasmid as a template, and the ampicillin resistance gene (AMP fragment) was amplified by PCR. The primer sequences are shown in Table 2, the PCR reaction system is shown in Table 3, and the PCR reaction conditions are as follows: 95℃ pre-denaturation for 3min; 95℃ denaturation for 30s, 70℃ annealing for 30s, 72℃ extension for 1min, 35 cycles; 72℃ final extension for 5min.

[0081] Table 2 Primer sequences

[0082]

[0083] Table 3 Homologous arm PCR reaction system

[0084]

[0085] The upstream and downstream homology arms and the ampicillin resistance gene fragment were subjected to agarose gel electrophoresis. The results were as follows Figure 1 and Figure 2 As shown, the PCR reaction amplified the upstream and downstream homology arms of the ectA gene, which were 600 bp respectively, and the ampicillin resistance gene, which was 800 bp. The target bands were recovered and purified according to the steps of the OMEGA gel recovery kit and stored in a 4°C refrigerator.

[0086] 2. Plasmid digestion

[0087] The PKC1139 plasmid (plasmid map as shown in Figure 3 The enzyme digestion system is shown in Table 4. The reaction procedure is: 37°C for 3h, 65°C for inactivation, and 4°C for storage. After the enzymatic digestion reaction, the enzyme digestion product and the original plasmid were subjected to agarose gel electrophoresis at the same time. Figure 4 As shown in (1 is the double-enzyme-digested PKC1139 plasmid, 2 is the original PKC1139 plasmid), the double-enzyme-digested PKC1139 plasmid was successful, and the restriction sites of the PKC1139 plasmid are as follows Figure 5 The double-digested PKC1139 plasmid band was recovered using the OMEGA gel recovery kit and used as a template for plasmid ligation reaction.

[0088] Table 4 Plasmid double restriction enzyme digestion system

[0089]

[0090] 3. Connecting the homology arms to the plasmid vector

[0091] The recovered double-digested PKC1139 plasmid was used as a template and cloned IIOne Step CloningKit C113 ligase ligated the template plasmid with the upstream homology arm, AMP fragment, and downstream homology arm fragments of the ectA gene at 37°C for 30 minutes, and then stored at 4°C. The enzyme ligation reaction system is shown in Table 5.

[0092] Table 5 One Step Cloning Kit ligase enzyme ligation reaction system

[0093]

[0094]

[0095] Transfer the ligation solution into E.coli DH5α competent cells, add 8μL IPTG and 40μL X-gal, and coat on LB plate containing 50μg / mL apramycin. Incubate at 37℃ overnight. White colonies are positive clones. Pick single white colonies and culture them in 1.5mL EP tubes. Extract plasmid DNA and verify that the PCR band size of positive colonies is 2000bp with primers ectA-UF / ectA-DR. Figure 6 As shown, it proves that the ectA gene knockout vector was successfully constructed. The plasmid with the correct plasmid PCR band was sent to Sangon Biotech (Shanghai) Co., Ltd. for sequencing. After SnapGen alignment, the successfully constructed ectA gene knockout vector was named PKC1139-ΔectA knockout vector and stored in a -80°C refrigerator with glycerol.

[0096] The schematic diagram of the construction process of the PKC1139-ΔectA knockout vector is shown in Figure 7 shown.

[0097] Example 2

[0098] This example provides Streptomyces lincomyces ΔectA in which the ectA gene is replaced by the AMP gene.

[0099] 1. Conjugation transfer between Streptomyces lincomyces and Escherichia coli

[0100] Transform the PKC1139-ΔectA knockout vector into E. coli ET12567 shuttle competent cells and spread them on triple-antibody LB plates for overnight culture. Pick a single clone colony and expand it in LB liquid, extract plasmid DNA, and verify the positive colony with primers ectA-UF / ectA-DR. The positive clone is a 2000bp band, such as Figure 8 shown.

[0101] Donor strain: Inoculate ET12567 E. coli competent cells containing the knockout vector into 50mL LB medium (containing apramycin, kanamycin, and chloramphenicol) at an inoculation volume of 1:100, and shake at 37°C and 220r / min for 3-4h. Take 5mL of bacterial solution, centrifuge at 4°C and 5000r / min for 5min, and remove the supernatant. Add 5mL LB (MgCl2, no antibiotics), vortex, centrifuge at 4°C and 5000r / min for 5min, remove the supernatant, and repeat twice. Finally, add 500μL LB and mix well by pipetting.

[0102] Recipient strain: Streptomyces lincomyces NBRC13054 was spread on a WL-50 solid plate. Scrape 1-2 cm 2 The spores were inoculated into 40mL of ISP-2 medium, cultured at 28℃ and 250r / min for 2-3 days. Observe whether the mycelium of Streptomyces lincosus is finely and evenly dispersed in the ISP-2 medium. Take 5mL of bacterial solution and centrifuge at 4000r / min for 5min to remove the supernatant; then add an equal volume of 10% glycerol, centrifuge at 4000r / min for 5min to remove the supernatant and wash the mycelium; then add an equal volume of 2×YT medium, centrifuge at 4000r / min for 5min to remove the supernatant, repeat the washing twice; finally, add 500μL of 2×YT to resuspend and mix thoroughly.

[0103] Vortex 500 μL of mycelium and 500 μL of ET12567 competent cells (donor strain) containing knockout vectors, centrifuge at 5000 r / min for 5 min, and discard part (200 μL) of the supernatant. Pipette 100 μL of the mixed bacterial solution and spread it on a non-antibiotic WL-50 plate, culture it in a 28°C incubator until a layer of mist-like bacteria grows on the WL-50 plate, and then cover it with 1 mL of a mixed antibiotic aqueous solution containing 0.5 mg / mL sodium nalidixic acid and 1 mg / mL apramycin. After drying in a clean bench, invert and culture it in a 28°C incubator until conjugants grow.

[0104] 2. Screening of strains with ectA gene deletion

[0105] According to the principle of homologous recombination (such as Fig. 9 The double exchange strains were screened. The conjugates were cultured in ISP-2 liquid medium and their genomic DNA was extracted.

[0106] Design detection primers JCA-F / JCA-R 500bp outside the upstream and downstream homology arms of the ectA gene knockout fragment, and detect the knockout of the target gene by PCR. The schematic diagram of the detection primer design is shown in Fig.10 The detection primer sequences are shown in Table 6.

[0107] Table 6 Detection primers

[0108]

[0109] If the target fragment is successfully knocked out and replaced (i.e., the ectA gene is successfully replaced by the AMP gene), the PCR band size should be around 2800 bp. If the target fragment is not knocked out and replaced, the PCR band size should be 2500 bp. The electrophoresis diagram of the PCR product is as follows: Fig.11 As shown, the target fragment was successfully knocked out and replaced.

[0110] The product was sent for sequencing, and the sequencing results were compared to further determine whether the target gene was successfully knocked out. The sequencing results showed that the ectA gene in Streptomyces lincosus was successfully replaced. The successfully transformed strain was named ΔectA.

[0111] 3. Plasmid elimination

[0112] The PKC1139 plasmid is a thermosensitive plasmid that contains a high temperature condition-deficient replication initiation site pSG5 and does not replicate at 37°C. The conjugates that were successfully transferred by conjugation were cultured on a non-resistance plate at 37°C for three consecutive generations to cause the PKC1139-ΔectA plasmid to be lost. The ectA gene knockout strain ΔectA, which had been subcultured multiple times at 37°C, was cultured on a non-resistance WL-50 spore-forming plate at 28°C. After spores grew, spores from the same single colony were picked and cultured as controls on a 25 μg / mL Apr-resistant WL-50 plate and a non-resistance WL-50 spore-forming plate. The growth status of the spores on the Apr-resistant WL-50 plate and the non-resistance WL-50 plate is shown in Figure 2. Fig.12 As shown, the ectA gene knockout strain ΔectA can grow normally and produce spores on the Apr-free plate, but cannot grow normally on the Apr-resistant plate, indicating that the PKC1139-ΔectA knockout vector was successfully eliminated.

[0113] 4. Growth curve determination of ΔectA mutant

[0114] The ectA gene-deficient ΔectA mutant (i.e., the ΔectA mutant with the PKC1139-ΔectA knockout vector eliminated) and the lincomyces NBRC13054 strain stored in glycerol at -80°C were inoculated into ISP-2 liquid medium for activation, and then spread on WL-50 solid medium. After spore production, 1 cm 2The spore culture medium was inoculated into 40 mL of ISP-2 liquid culture medium and cultured in a shake flask for 36 h. According to the principle of equal amount, 1 mL was inoculated into ISP-2 culture medium and cultured in a shake flask at 28 ° C and 280 r / min for 7 days. Starting from day 0, samples were taken every 12 h, and 3 biological replicates were set each time. After all the bacteria in the culture medium were filtered out, they were dried in a 50 ° C oven and the dry weight of the bacteria was weighed.

[0115] By measuring the dry weight of mycelium, the growth curve of the ΔectA mutant and the wild-type NBRC13054 strain was drawn, as shown in Fig.13 As shown. The growth curves of the ΔectA mutant and the wild-type NBRC13054 strain were basically the same, and the dry weight of the bacteria reached the maximum at 48h, which was 4.15g / L and 3.04g / L respectively, indicating that the loss of the ectA gene had no significant effect on the normal growth of Streptomyces lincomycin NBRC13054. The ΔectA mutant had a higher bacterial mass than the wild-type NBRC13054 strain at 0-12h, which may be due to the loss of the ectA gene, which reduced the consumption of precursors and energy, and the precursors and energy in the ectoine synthesis pathway were more enriched in the primary metabolic pathway, further promoting the growth of the strain.

[0116] Example 3

[0117] This embodiment provides a method for increasing the yield of lincomycin by using a ΔectA mutant strain of Streptomyces lincomycin with a deleted ectA gene.

[0118] The ectA gene-deficient ΔectA mutant was cultured on a WL-50 solid plate at 28°C for 7 days and a 1 cm 2 The bacterial block was cultured in the seed culture medium for 48 hours, and then inoculated into the primary fermentation medium at a 2% inoculation rate, and fermented in a shake flask at 28°C and 280 r / min for 3 days. Then, the inoculation rate was inoculated into the secondary fermentation medium at a 2% inoculation rate, and fermented in a shake flask at 28°C and 280 r / min for 7 days.

[0119] Lincomycin detection: After the fermentation is completed, take 2 mL of fermentation liquid, centrifuge and take the supernatant, then add 1.5 times the volume of anhydrous ethanol, and filter the supernatant after centrifugation with a 0.22 μm organic phase filter membrane. The treated fermentation liquid is detected by HPLC. Detection conditions: The chromatographic column uses Agilent ZORBAX SB-C18 (4.6×250mm, 5μm), the detection wavelength is 210nm, the mobile phase is 50mmol / L ammonium acetate (pH=9) and methanol (volume ratio is 20:80), the flow rate is 0.4mL / min, the injection volume is 10μL, and the liquid chromatography instrument is Agilent 1260 high performance liquid chromatograph.

[0120] Standard curve drawing: Weigh a certain amount of lincomycin standard, prepare 10 mg / mL lincomycin stock solution, and then dilute it to 25 mg / L, 50 mg / L, 100 mg / L, 300 mg / L, 500 mg / L in sequence. According to the lincomycin liquid phase detection conditions, measure the peak area of ​​each concentration standard, and fit the standard curve with lincomycin concentration as the horizontal axis and peak area as the vertical axis, as shown in the figure. Fig.14 The linear regression equation obtained is: y = 5.6688x + 89.27, R 2 =0.9961.

[0121] The peak time of lincomycin standard is 8min 50s. Fig.15 The chromatogram of lincomycin after the fermentation broth of the ΔectA mutant and the wild strain NBRC13054 was diluted 5 times with ethanol is shown in Fig.16 As shown in Figure A, the results were put into the regression equation to calculate the lincomycin production of the mutant strain compared to the wild strain. Fig.16 As shown in Figure B.

[0122] The results showed that the average yield of lincomycin in the fermentation broth of the ΔectA mutant strain could reach 201.47 mg / L, and the highest yield could reach 239.67 mg / L. The average yield of lincomycin in the fermentation broth of the wild-type NBRC13054 strain was 115.50 mg / L, and the yield of lincomycin produced by the ΔectA mutant strain was 107.5% higher than that of the wild-type NBRC13054 strain. The results showed that after the ectA gene was deleted, the yield of lincomycin increased significantly, that is, the synthesis pathway of other secondary metabolites in Streptomyces lincomycin could be blocked, the synthesis of other secondary metabolites could be reduced, and the precursor substances could be enriched as much as possible in the lincomycin synthesis pathway, thereby increasing the yield of lincomycin in Streptomyces lincomycin.

[0123] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent substitution or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for increasing lincomycin production by knocking out the ectA gene of Streptomyces lincomycin. It is characterized in that The ectA gene of Streptomyces lincomycin is knocked out, and the obtained mutant is used to ferment and produce lincomycin. The nucleotide sequence of the ectA gene is shown in SEQ ID NO.

1.

2. A method for constructing a mutant strain of Streptomyces lincomyces with ectA gene deletion, It is characterized in that The ectA gene in Streptomyces lincomyces is replaced by a gene unrelated to ectoine synthesis through genetic engineering; wherein the nucleotide sequence of the ectA gene is shown in SEQ ID NO.

1.

3. The construction method according to claim 2, It is characterized in that The construction method uses Streptomyces lincomyces NBRC13054 as the starting strain.

4. The construction method according to claim 2, It is characterized in that The gene unrelated to ectoine synthesis is an ampicillin resistance gene.

5. The construction method according to any one of claims 2 to 4, It is characterized in that The specific steps include: S1. Using the genomic DNA of Streptomyces lincomyces NBRC13054 as a template, and using ectA-UF and ectA-UR as well as ectA-DF and ectA-DR as primers, the upstream and downstream homologous arms of the ectA gene were amplified by PCR reaction, respectively. The nucleotide sequences of ectA-UF, ectA-UR, ectA-DF and ectA-DR are shown in SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4 and SEQ ID NO.5, respectively. Using the pUC57-AMP plasmid as a template, and using AMP-F and AMP-R as primers, the ampicillin resistance gene was amplified by PCR reaction. The nucleotide sequences of AMP-F and AMP-R are shown in SEQ ID NO.6 and SEQ ID NO.7, respectively. S2, double-digest the PKC1139 plasmid, and connect the resulting digestion product with the upstream and downstream homology arms and the ampicillin resistance gene obtained in S1 to obtain the PKC1139-ΔectA knockout vector; S3, transforming the PKC1139-ΔectA knockout vector into competent Escherichia coli cells, and culturing them as donor strains; S4. The donor strain and mycelium of Streptomyces lincomyces are co-cultured in an antibiotic-free culture medium to form a mist of bacteria, which are then covered with antibiotics and cultured until conjugates grow. The mutant strain of Streptomyces lincomyces with ectA gene deletion is obtained through screening.

6. The construction method according to claim 5, It is characterized in that The endonucleases used for double digestion of PKC1139 plasmid in S2 were XbaI and EcoRI.

7. The construction method according to claim 5, It is characterized in that Using Clon in S2 IIOne StepCloning Kit C113 ligase connects the enzyme cleavage product with the upstream and downstream homology arms and the ampicillin resistance gene through enzyme ligation reaction.

8. The construction method according to claim 5, It is characterized in that The E. coli competent cells described in S3 are ET12567 E. coli competent cells; the Streptomyces lincomyces described in S4 are Streptomyces lincomyces NBRC13054.

9. An ectA gene-deficient mutant of Streptomyces lincomyces constructed by the construction method according to any one of claims 2 to 8.

10. Use of the ectA gene-deficient mutant of Streptomyces lincomycin according to claim 9 in the fermentation production of lincomycin.

Citation Information

Cited By

  • Method for improving lincomycin yield by transforming streptomyces lincomycin SLCG3904 gene and application

    CN119799607A